Epigenetics and microRNAs in cancer

A Ramassone, S Pagotto, A Veronese… - International journal of …, 2018 - mdpi.com
The ability to reprogram the transcriptional circuitry by remodeling the three-dimensional
structure of the genome is exploited by cancer cells to promote tumorigenesis. This …

Mechanisms controlling microRNA expression in tumor

S Chen, Y Wang, D Li, H Wang, X Zhao, J Yang… - Cells, 2022 - mdpi.com
MicroRNAs (miRNAs) are widely present in many organisms and regulate the expression of
genes in various biological processes such as cell differentiation, metabolism, and …

Micro RNA s: A novel potential biomarker for diagnosis and therapy in patients with non‐small cell lung cancer

Q Zhou, SX Huang, F Zhang, SJ Li, C Liu… - Cell …, 2017 - Wiley Online Library
Background Lung cancer is still one of the most serious causes of cancer‐related deaths all
over the world. Micro RNA s (mi RNA s) are defined as small non‐coding RNA s which could …

MicroRNA in lung cancer metastasis

SG Wu, TH Chang, YN Liu, JY Shih - Cancers, 2019 - mdpi.com
Tumor metastasis is a hallmark of cancer, with distant metastasis frequently developing in
lung cancer, even at initial diagnosis, resulting in poor prognosis and high mortality …

A systematic review of progress toward unlocking the power of epigenetics in NSCLC: Latest updates and perspectives

A Sulewska, L Pilz, C Manegold, R Ramlau… - Cells, 2023 - mdpi.com
Epigenetic research has the potential to improve our understanding of the pathogenesis of
cancer, specifically non-small-cell lung cancer, and support our efforts to personalize the …

The phosphodiesterase 2A controls lymphatic junctional maturation via cGMP-dependent notch signaling

C Carlantoni, LMH Liekfeld, SA Hemkemeyer… - Developmental Cell, 2024 - cell.com
The molecular mechanisms by which lymphatic vessels induce cell contact inhibition are not
understood. Here, we identify the cGMP-dependent phosphodiesterase 2A (PDE2A) as a …

[HTML][HTML] miR-449a suppresses tumor growth, migration, and invasion in non-small cell lung cancer by targeting a HMGB1-mediated NF-κB signaling pathway

D Wu, J Liu, J Chen, H He, H Ma, X Lv - Oncology research, 2019 - ncbi.nlm.nih.gov
MicroRNAs (miRNAs) have been reported to be involved in many human cancers and tumor
progression. The dysregulation of miR-449a is found in many types of malignancies and is …

Epithelial-to-mesenchymal transition and MicroRNAs in lung cancer

A Legras, N Pécuchet, S Imbeaud, K Pallier, A Didelot… - Cancers, 2017 - mdpi.com
Despite major advances, non-small cell lung cancer (NSCLC) remains the major cause of
cancer-related death in developed countries. Metastasis and drug resistance are the main …

Molecular Pathogenesis of Colorectal Cancer: Impact of Oncogenic Targets Regulated by Tumor Suppressive miR-139-3p

R Yasudome, N Seki, S Asai, Y Goto, Y Kita… - International Journal of …, 2022 - mdpi.com
We recently determined the RNA sequencing-based microRNA (miRNA) expression
signature of colorectal cancer (CRC). Analysis of the signature showed that the expression …

Epigenetic regulation of EMT in non-small cell lung cancer

K O'Leary, A Shia, P Schmid - Current cancer drug targets, 2018 - ingentaconnect.com
Lung cancer remains the most diagnosed cancer in the world, with a high mortality rate and
fewer therapeutic options. The most common lung cancer is non-small cell, consisting of …